Arovella Therapeutics (Australia) Market Value
| ALA Stock | 0.19 0.01 5.56% |
| Symbol | Arovella |
Arovella Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arovella Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arovella Therapeutics.
| 12/19/2024 |
| 01/18/2025 |
If you would invest 0.00 in Arovella Therapeutics on December 19, 2024 and sell it all today you would earn a total of 0.00 from holding Arovella Therapeutics or generate 0.0% return on investment in Arovella Therapeutics over 30 days. Arovella Therapeutics is related to or competes with Aneka Tambang, Rio Tinto, BHP Group, Block, Suncorp, Unibail Rodamco, and Aristocrat Leisure. Arovella Therapeutics is entity of Australia More
Arovella Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arovella Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arovella Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.15 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 20.05 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 5.88 |
Arovella Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arovella Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arovella Therapeutics' standard deviation. In reality, there are many statistical measures that can use Arovella Therapeutics historical prices to predict the future Arovella Therapeutics' volatility.| Risk Adjusted Performance | 0.0119 | |||
| Jensen Alpha | 0.0174 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.03) |
Arovella Therapeutics Backtested Returns
Currently, Arovella Therapeutics is out of control. Arovella Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0209, which signifies that the company had a 0.0209% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Arovella Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Arovella Therapeutics' Mean Deviation of 3.19, risk adjusted performance of 0.0119, and Downside Deviation of 6.15 to double-check if the risk estimate we provide is consistent with the expected return of 0.0888%. Arovella Therapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Arovella Therapeutics are expected to decrease at a much lower rate. During the bear market, Arovella Therapeutics is likely to outperform the market. Arovella Therapeutics right now shows a risk of 4.25%. Please confirm Arovella Therapeutics information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Arovella Therapeutics will be following its price patterns.
Auto-correlation | -0.25 |
Weak reverse predictability
Arovella Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Arovella Therapeutics time series from 19th of December 2024 to 3rd of January 2025 and 3rd of January 2025 to 18th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arovella Therapeutics price movement. The serial correlation of -0.25 indicates that over 25.0% of current Arovella Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Arovella Therapeutics lagged returns against current returns
Autocorrelation, which is Arovella Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arovella Therapeutics' stock expected returns. We can calculate the autocorrelation of Arovella Therapeutics returns to help us make a trade decision. For example, suppose you find that Arovella Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arovella Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arovella Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arovella Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arovella Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Arovella Therapeutics Lagged Returns
When evaluating Arovella Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arovella Therapeutics stock have on its future price. Arovella Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arovella Therapeutics autocorrelation shows the relationship between Arovella Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Arovella Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arovella Stock Analysis
When running Arovella Therapeutics' price analysis, check to measure Arovella Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arovella Therapeutics is operating at the current time. Most of Arovella Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arovella Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arovella Therapeutics' price. Additionally, you may evaluate how the addition of Arovella Therapeutics to your portfolios can decrease your overall portfolio volatility.